Correlation Between Mosaic Immunoengineerin and Zenith Capital

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mosaic Immunoengineerin and Zenith Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mosaic Immunoengineerin and Zenith Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mosaic Immunoengineering and Zenith Capital Corp, you can compare the effects of market volatilities on Mosaic Immunoengineerin and Zenith Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mosaic Immunoengineerin with a short position of Zenith Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mosaic Immunoengineerin and Zenith Capital.

Diversification Opportunities for Mosaic Immunoengineerin and Zenith Capital

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Mosaic and Zenith is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Mosaic Immunoengineering and Zenith Capital Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenith Capital Corp and Mosaic Immunoengineerin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mosaic Immunoengineering are associated (or correlated) with Zenith Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenith Capital Corp has no effect on the direction of Mosaic Immunoengineerin i.e., Mosaic Immunoengineerin and Zenith Capital go up and down completely randomly.

Pair Corralation between Mosaic Immunoengineerin and Zenith Capital

Given the investment horizon of 90 days Mosaic Immunoengineering is expected to generate 0.84 times more return on investment than Zenith Capital. However, Mosaic Immunoengineering is 1.19 times less risky than Zenith Capital. It trades about 0.19 of its potential returns per unit of risk. Zenith Capital Corp is currently generating about -0.21 per unit of risk. If you would invest  66.00  in Mosaic Immunoengineering on November 4, 2024 and sell it today you would earn a total of  33.00  from holding Mosaic Immunoengineering or generate 50.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy90.91%
ValuesDaily Returns

Mosaic Immunoengineering  vs.  Zenith Capital Corp

 Performance 
       Timeline  
Mosaic Immunoengineering 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Mosaic Immunoengineering are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain primary indicators, Mosaic Immunoengineerin showed solid returns over the last few months and may actually be approaching a breakup point.
Zenith Capital Corp 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Zenith Capital Corp are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Zenith Capital reported solid returns over the last few months and may actually be approaching a breakup point.

Mosaic Immunoengineerin and Zenith Capital Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mosaic Immunoengineerin and Zenith Capital

The main advantage of trading using opposite Mosaic Immunoengineerin and Zenith Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mosaic Immunoengineerin position performs unexpectedly, Zenith Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenith Capital will offset losses from the drop in Zenith Capital's long position.
The idea behind Mosaic Immunoengineering and Zenith Capital Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Global Correlations
Find global opportunities by holding instruments from different markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets